Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.
Nisha R AcharyaCaleb D EbertNicole K KellyTravis C PorcoAthimalaipet V RamananBenjamin F Arnoldnull nullPublished in: Trials (2020)
ClinicalTrials.gov NCT03816397. Registered on 25 January 2019. EudraCT 2019-000412-29. Registered on 17 January 2019.